Advanced Medical Optics completes $808 million acquisition of IntraLase

By Lisa Kerner

Charlotte, N.C., April 2 - Advanced Medical Optics, Inc. completed its $25.00 per share, or $808 million total, cash acquisition of IntraLase Corp. first announced on Jan. 8.

IntraLase stockholders approved the merger on Friday and the company said it will voluntarily delist its shares from the Nasdaq Global Market effective Tuesday.

"We have taken a major step toward defining a new standard of care in laser vision correction," Advanced Medical chairman, president and chief executive officer Jim Mazzo said in a company news release.

"Along with the recently announced acquisition of WaveFront Sciences, Advanced Medical Optics now owns the most advanced corneal refractive technologies on the market with the ability to offer a full systems approach that is without peer in the industry."

The acquisition also gives Advanced Medical entry into the corneal transplant market with the IntraLase enabled keratoplasty technology.

Advanced Medical Optics is a global ophthalmic surgical and eye care products company based in Santa Ana, Calif.

IntraLase, located in Irvine, Calif., designs, develops and manufactures an ultra-fast laser used in refractive and corneal surgery.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.